Howe & Rusling Inc Acadia Pharmaceuticals Inc Transaction History

Howe & Rusling Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$14.11 - $18.27 $705 - $913	-50 Reduced 48.08%	54 $1,000
Q2 2022 Aug 15, 2022	BUY	$13.01 - $27.22 $585 - $1,224	45 Added 76.27%	104 $1,000
Q4 2021 Feb 14, 2022	SELL	$16.79 - $27.09 $654 - $1,056	-39 Reduced 39.8%	59 $1,000
Q3 2021 Nov 15, 2021	BUY	$15.78 - $24.77 $520 - $817	33 Added 50.77%	98 $2,000
Q1 2021 May 13, 2021	SELL	$25.02 - $54.99 $116,718 - $256,528	-4,665 Reduced 98.63%	65 $2,000
Q1 2020 May 14, 2020	BUY	$31.65 - $46.87 $60,135 - $89,053	1,900 Added 67.14%	4,730 $200,000
Q3 2017 Oct 18, 2017	BUY	$29.49 - $38.37 $83,456 - $108,587	2,830	2,830 $107,000

279

156M

901K

314K

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.76B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

Get notified when there are updates to the investment portfolio of Howe & Rusling Inc, based on Form 13F filings with the SEC.

Stay updated on Howe & Rusling Inc with notifications on news.